NCT01042314View on ClinicalTrials.gov

Drug-Drug Interaction Study With Aricept® (Donepezil)

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Alzheimer Disease
Interventions
DRUG

Donepezil

Tablets, Oral, 5 mg, Once Daily, Days 1-28

DRUG

BMS-708163

Capsule, Oral, 125 mg, Once Daily, Days 15-28

Trial Locations (1)

21225

Parexel International - Baltimore Epcu, Baltimore

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY